Literature DB >> 3484718

Cyclosporine affects the function of antigen-presenting cells.

A M Varey, B R Champion, A Cooke.   

Abstract

The immunosuppressant drug cyclosporine (CsA) is known to affect T-cell function. We have studied the effect of CsA on the specific proliferative response of T-cell lines to antigen. In addition to blocking IL-2 release by specifically activated T-cell lines, CsA also affected the ability of irradiated spleen cells to present preprocessed antigen to T-cell lines. Irradiated spleen cells pulsed with antigen for 2 hr were able to stimulate a proliferative response in T-cell lines. Following a 2-hr pulse with CsA, antigen presentation by these irradiated spleen cells was reduced significantly, suggesting that CsA not only affects T cells, but also affects the function of antigen-presenting cells.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3484718      PMCID: PMC1453899     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  14 in total

1.  Autoreactive T-cell lines specific for mouse thyroglobulin.

Authors:  B R Champion; A M Varey; D Katz; A Cooke; I M Roitt
Journal:  Immunology       Date:  1985-03       Impact factor: 7.397

2.  Induction of regulatory T-lymphocyte responses by liposomes carrying major histocompatibility complex molecules and foreign antigen.

Authors:  P Walden; Z A Nagy; J Klein
Journal:  Nature       Date:  1985 May 23-29       Impact factor: 49.962

3.  A comparison of the stimulatory activities of lymphoid dendritic cells and macrophages in T proliferative responses to various antigens.

Authors:  C Guidos; M Wong; K C Lee
Journal:  J Immunol       Date:  1984-09       Impact factor: 5.422

4.  Effect of cyclosporin A on human lymphocyte responses in vitro. I. CsA allows for the expression of alloantigen-activated suppressor cells while preferentially inhibiting the induction of cytolytic effector lymphocytes in MLR.

Authors:  A D Hess; P J Tutschka
Journal:  J Immunol       Date:  1980-06       Impact factor: 5.422

5.  Differential effects of cyclosporin-A on lymphocyte subpopulations.

Authors:  S B Leapman; R S Filo; E J Smith; P G Smith
Journal:  Transplant Proc       Date:  1981-03       Impact factor: 1.066

6.  Effects of the new anti-lymphocytic peptide cyclosporin A in animals.

Authors:  J F Borel; C Feurer; C Magnée; H Stähelin
Journal:  Immunology       Date:  1977-06       Impact factor: 7.397

7.  Selective effects of cyclosporin A on functional B cell subsets in the mouse.

Authors:  A Kunkl; G G Klaus
Journal:  J Immunol       Date:  1980-12       Impact factor: 5.422

8.  Cyclosporin A inhibits T-cell growth factor gene expression at the level of mRNA transcription.

Authors:  M Krönke; W J Leonard; J M Depper; S K Arya; F Wong-Staal; R C Gallo; T A Waldmann; W C Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

9.  Analysis of cloned T cell function. I. Dissection of cloned T cell proliferative responses using cyclosporin A.

Authors:  C G Orosz; R K Fidelus; D C Roopenian; M B Widmer; R M Ferguson; F H Bach
Journal:  J Immunol       Date:  1982-11       Impact factor: 5.422

10.  Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2.

Authors:  D Bunjes; C Hardt; M Röllinghoff; H Wagner
Journal:  Eur J Immunol       Date:  1981-08       Impact factor: 5.532

View more
  7 in total

1.  Lack of demonstrable effect of cyclosporin A on human epidermal Langerhans cell function.

Authors:  J Péguet-Navarro; M Slaats; J Thivolet
Journal:  Arch Dermatol Res       Date:  1991       Impact factor: 3.017

2.  Immunosuppressive activity of FK-506 in rats: flow cytometric analysis of lymphocyte populations in blood, spleen and thymus during treatment and following drug withdrawal.

Authors:  J Woo; C S Ross; J I Milton; A W Thomson
Journal:  Clin Exp Immunol       Date:  1990-01       Impact factor: 4.330

3.  Complete prevention of the clinical expression of adjuvant-induced arthritis in rats by cyclosporin-A and lobenzarit: the regulation of lymph node cell populations and cytokine production.

Authors:  D R Haynes; S J Gadd; M W Whitehouse; G Mayrhofer; B Vernon-Roberts
Journal:  Inflamm Res       Date:  1996-04       Impact factor: 4.575

4.  A complex component modulating immune-deficient cells in leprosy patients leading to loss of viability of Mycobacterium leprae--a possible vaccine.

Authors:  J Marolia; P Robinson; P R Mahadevan
Journal:  Clin Exp Immunol       Date:  1990-01       Impact factor: 4.330

5.  Antigen presentation and HLA-DR expression by FK-506-treated human monocytes.

Authors:  J Woo; D J Propper; A W Thomson
Journal:  Immunology       Date:  1990-12       Impact factor: 7.397

6.  Cyclosporin A enhances elimination of intracellular L. major parasites by murine macrophages.

Authors:  C Bogdan; H Streck; M Röllinghoff; W Solbach
Journal:  Clin Exp Immunol       Date:  1989-01       Impact factor: 4.330

7.  Effect of cyclosporine on distribution of macrophage subpopulations in rat hepatic allograft.

Authors:  Y Yamaguchi; M Misumi; K Mori; N Takata; M Goto; Y Makino; N Kikuchi; H Hamaguchi; N Hisama; M Takeya
Journal:  Dig Dis Sci       Date:  1993-04       Impact factor: 3.199

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.